Emily Robinson

Management of Antiangiogenic Therapy-Induced Hypertension

Nilka de Jesús-González, Emily Robinson, Javid J. Moslehi et al. · Hypertension · 2012 · 117 citations · Full text

Hypertension, Antiangiogenic Therapy-induced Hypertension, Cardiovascular Disease +7

Suppression of the Nitric Oxide Pathway in Metastatic Renal Cell Carcinoma Patients Receiving Vascular Endothelial Growth Factor–Signaling Inhibitors

Emily Robinson, Eliyahu V. Khankin, Toni K. Choueiri et al. · Hypertension · 2010 · 111 citations · Full text

Hypertension, Human Growth, Nitric Oxide +24

Rapid Development of Hypertension and Proteinuria with Cediranib, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor

Emily Robinson, Ursula A. Matulonis, Percy Ivy et al. · Clinical Journal of the American Society of Nephrology · 2010 · 87 citations

Physical Activity and Albuminuria

Emily Robinson, Naomi D.L. Fisher, John P. Forman et al. · American Journal of Epidemiology · 2010 · 67 citations · Full text

Physical Activity, Future Cardiovascular Disease, Metabolic Syndrome +18

A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI

Mallika L. Mendu, George Ciociolo, Sarah McLaughlin et al. · Clinical Journal of the American Society of Nephrology · 2017 · 67 citations · Full text